Cuprina Holdings (Cayman) Limited Class A Ordinary Shares Total Liabilities
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares total liabilities. Based on the latest financial reports, Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) has total liabilities worth $3.45 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Cuprina Holdings (Cayman) Limited Class (CUPR) defensive interval to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (2021–2025)
Total liabilities of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares from 2021 to 2025. This chart illustrates how Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's total liabilities have evolved over time, based on quarterly financial data. Explore CUPR strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares Competitors by Total Liabilities
The table below lists competitors of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Trainline Plc
LSE:TRN
|
UK | GBX452.09 Million |
|
Orgenesis Inc
NASDAQ:ORGS
|
USA | $53.62 Million |
|
EAM Solar ASA
OL:EAM
|
Norway | Nkr8.52 Million |
|
City Chic Collective Ltd
AU:CCX
|
Australia | AU$68.62 Million |
|
Zenta Group Company Limited
NASDAQ:ZTG
|
USA | $407.14K |
|
DevPort AB (publ)
ST:DEVP-B
|
Sweden | Skr120.96 Million |
|
ViroGates A/S
CO:VIRO
|
Denmark | Dkr9.98 Million |
|
Organoclick AB
ST:ORGC
|
Sweden | Skr121.59 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Cuprina Holdings (Cayman) Limited Class (CUPR) total assets.
Liquidity & Leverage Metrics
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares Total Liabilities Ratios Explained
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.35 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.68 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (2021–2025)
The table below shows the annual total liabilities of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $3.45 Million | -44.41% |
| 2024-12-31 | $6.20 Million | +38.41% |
| 2023-12-31 | $4.48 Million | +39.46% |
| 2022-12-31 | $3.21 Million | +96.41% |
| 2021-12-31 | $1.64 Million | -- |
About Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collag… Read more